Alvotech - Ordinary Shares (NQ:ALVO)
All News about Alvotech - Ordinary Shares
Alvotech Announces Australian Marketing Authorization for AVT02, a Biosimilar to Humira®
November 14, 2022
From Alvotech
Via GlobeNewswire
Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November
October 26, 2022
From Alvotech
Via GlobeNewswire
Alvotech Appoints Sarah Tanksley as Chief Quality Officer
October 11, 2022
From Alvotech
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022 ↗
September 07, 2022
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free